Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

View source ↗

Summary

Real world evidence study evaluating the effectiveness of paritaprevir/ritonavir-ombitasvir, with or without dasabuvir and ribavirin, in participants with chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ombitasvir (ombitasvir)
• Ribavirin (ribavirin)
• paritaprevir/ritonavir-ombitasvir (paritaprevir/ritonavir-ombitasvir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C | Status: COMPLETED | Results posted: 2019-03-15